Summary:
- This article discusses the creation of a $40 million longevity fund, which aims to invest in research and technologies that could potentially make death "optional" in the future.
- The fund is being launched by a group of scientists, entrepreneurs, and investors who believe that significant advancements in fields like regenerative medicine, gene therapy, and cellular reprogramming could lead to radical life extension or even immortality.
- The article highlights the potential benefits of such research, including the ability to dramatically improve human health and quality of life, as well as the challenges and ethical considerations that come with the pursuit of extended lifespans.